Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
about
Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerInhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapyIncreased ceramide production sensitizes breast cancer cell response to chemotherapy.Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation.Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain.
P2860
Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Treatment challenges for commu ...... egative advanced breast cancer
@ast
Treatment challenges for commu ...... egative advanced breast cancer
@en
Treatment challenges for commu ...... egative advanced breast cancer
@nl
type
label
Treatment challenges for commu ...... egative advanced breast cancer
@ast
Treatment challenges for commu ...... egative advanced breast cancer
@en
Treatment challenges for commu ...... egative advanced breast cancer
@nl
prefLabel
Treatment challenges for commu ...... egative advanced breast cancer
@ast
Treatment challenges for commu ...... egative advanced breast cancer
@en
Treatment challenges for commu ...... egative advanced breast cancer
@nl
P2860
P3181
P356
P1476
Treatment challenges for commu ...... egative advanced breast cancer
@en
P2093
William J Gradishar
P2860
P3181
P356
10.2147/CMAR.S98249
P407
P577
2016-01-01T00:00:00Z